Document is current

Article History

Received: 17 February 2021

Accepted: 20 October 2021

First Online: 4 November 2021

Declarations

:

: This study was conducted with the prior written authorization of the Research Ethics Boards of the University of Manitoba and the University of Alberta. All patients provided written informed consent prior to undergoing study related procedures and all study conduct was in accordance with the Tri-Council Policy Statement Guidelines for Research Involving Human Subjects. This study was registered on a clinical trials registry: ClinicalTrials.gov Trial identifier NCT01996696.

: All participants provided prior written informed consent to publish the study results at the time of study entry. No personal identifying data from patients was included in this manuscript.

: HQ discloses consultant fees from Sanofi, Bayer, Astellas, Pfizer, Merck, and Janssen outside the submitted work. BD discloses personal fees from Janssen, Bayer, Astellas, Ferring outside the submitted work.